| Year |
Citation |
Score |
| 2013 |
Pike LR, Singleton DC, Buffa F, Abramczyk O, Phadwal K, Li JL, Simon AK, Murray JT, Harris AL. Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival. The Biochemical Journal. 449: 389-400. PMID 23078367 DOI: 10.1042/Bj20120972 |
0.764 |
|
| 2012 |
Pike LR, Phadwal K, Simon AK, Harris AL. ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia. Molecular Biology Reports. 39: 10811-22. PMID 23090478 DOI: 10.1007/s11033-012-1975-3 |
0.621 |
|
| 2012 |
Phadwal K, Alegre-Abarrategui J, Watson AS, Pike L, Anbalagan S, Hammond EM, Wade-Martins R, McMichael A, Klenerman P, Simon AK. A novel method for autophagy detection in primary cells: Impaired levels of macroautophagy in immunosenescent T cells Autophagy. 8: 677-689. PMID 22302009 DOI: 10.4161/auto.18935 |
0.309 |
|
| 2012 |
Rzymski T, Petry A, KraÄun D, Rieß F, Pike L, Harris AL, Görlach A. The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene. 31: 3621-34. PMID 22105359 DOI: 10.1038/onc.2011.522 |
0.753 |
|
| 2012 |
Nanka O, Krejci E, Pesevski Z, Sedmera D, Smart N, Rossdeutsch A, Dube KN, Riegler J, Price AN, Taylor A, Muthurangu V, Turner M, Lythgoe MF, Riley PR, Kryvorot S, ... ... Pike L, et al. Poster session 3 Cardiovascular Research. 93: S92-S127. DOI: 10.1093/Cvr/Cvr336 |
0.565 |
|
| 2010 |
Yang J, Jubb AM, Pike L, Buffa FM, Turley H, Baban D, Leek R, Gatter KC, Ragoussis J, Harris AL. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Research. 70: 6456-66. PMID 20682797 DOI: 10.1158/0008-5472.CAN-10-0413 |
0.718 |
|
| 2010 |
Rzymski T, Milani M, Pike L, Buffa F, Mellor HR, Winchester L, Pires I, Hammond E, Ragoussis I, Harris AL. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene. 29: 4424-35. PMID 20514020 DOI: 10.1038/onc.2010.191 |
0.628 |
|
| 2009 |
Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, Generali D, Harris AL. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Research. 69: 4415-23. PMID 19417138 DOI: 10.1158/0008-5472.CAN-08-2839 |
0.675 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Qian JM, Akama-Garren E, Shin J, Gunasti L, Bang A, Pike LRG, Grassberger C, Schoenfeld JD. Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors. Advances in Radiation Oncology. 7: 100880. PMID 35097241 DOI: 10.1016/j.adro.2021.100880 |
0.169 |
|
| 2018 |
Pike LRG, Bang A, Mahal BA, Taylor A, Krishnan M, Spektor A, Cagney DN, Aizer AA, Alexander BM, Rahma O, Balboni T, Ott PA, Hodi FS, Schoenfeld JD. The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors. International Journal of Radiation Oncology, Biology, Physics. PMID 30227198 DOI: 10.1016/J.Ijrobp.2018.09.010 |
0.166 |
|
| 2018 |
Hwang WL, Pike LRG, Royce TJ, Mahal BA, Loeffler JS. Safety of combining radiotherapy with immune-checkpoint inhibition. Nature Reviews. Clinical Oncology. PMID 29872177 DOI: 10.1038/s41571-018-0046-7 |
0.166 |
|
| 2021 |
Yang DD, Mahal BA, Pike LRG. Biomarkers in Nonmetastatic Castrate-Resistant Prostate Cancer: A Step in the Right Direction. Jama Oncology. 7: 1014-1015. PMID 34081079 DOI: 10.1001/jamaoncol.2021.1358 |
0.156 |
|
| 2023 |
Skakodub A, Walch H, Tringale KR, Eichholz J, Imber BS, Vasudevan HN, Li BT, Moss NS, Hei Yu KK, Mueller BA, Powell S, Razavi P, Yu HA, Reis-Filho JS, Gomez D, ... ... Pike LRG, et al. Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nature Communications. 14: 4980. PMID 37591896 DOI: 10.1038/s41467-023-40793-x |
0.136 |
|
| 2015 |
Stachelek GC, Peterson-Roth E, Liu Y, Fernandez RJ, Pike LR, Qian JM, Abriola L, Hoyer D, Hungerford W, Merkel J, Glazer PM. YU238259 is a Novel Inhibitor of Homology-dependent DNA Repair that Exhibits Synthetic Lethality and Radiosensitization in Repair-deficient Tumors. Molecular Cancer Research : McR. PMID 26116172 DOI: 10.1158/1541-7786.Mcr-15-0036 |
0.135 |
|
| 2017 |
Pike LRG, Bang A, Ott P, Balboni T, Taylor A, Catalano P, Rawal B, Spektor A, Krishnan M, Cagney D, Alexander B, Aizer AA, Buchbinder E, Awad M, Gandhi L, et al. Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28662869 DOI: 10.1016/J.Radonc.2017.06.006 |
0.134 |
|
| 2024 |
Yu Y, Miao E, Pike LRG. Improved CNS Control With the Addition of Chemotherapy to Osimertinib-A Devil's Bargain? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2302699. PMID 38569123 DOI: 10.1200/JCO.23.02699 |
0.12 |
|
| 2007 |
Croke JM, Pike LR, MacPhee DJ. The focal adhesion protein Hic-5 is highly expressed in the rat myometrium during late pregnancy and labour and co-localizes with FAK. Reproductive Biology and Endocrinology : Rb&E. 5: 22. PMID 17550607 DOI: 10.1186/1477-7827-5-22 |
0.118 |
|
| 2019 |
Pike LRG, Wu J, Chen MH, Loffredo M, Renshaw AA, Pfail J, Kantoff PW, D'Amico AV. Time to PSA Nadir and the Risk of Death from Prostate Cancer following Radiation and Androgen Deprivation Therapy. Urology. PMID 30664895 DOI: 10.1016/j.urology.2018.11.056 |
0.114 |
|
| 2023 |
Miao E, Eichholz JE, Lebow ES, Flynn J, Zhang Z, Walch H, Hubbeling H, Beal K, Moss NS, Yu KK, Meng A, Kelly DW, Gomez DR, Li BT, Rimner A, ... ... Pike LRG, et al. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib. Lung Cancer (Amsterdam, Netherlands). 178: 57-65. PMID 36780766 DOI: 10.1016/j.lungcan.2023.02.005 |
0.097 |
|
| 2019 |
Fareed MM, Pike LRG, Bang A, Huynh MA, Taylor A, Spektor A, Awad MM, Ott PA, Krishnan M, Balboni TA, Schoenfeld JD. Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy. Frontiers in Oncology. 9: 199. PMID 30984622 DOI: 10.3389/fonc.2019.00199 |
0.093 |
|
| 2019 |
Mahal AR, Butler S, Franco I, Muralidhar V, Larios D, Pike LRG, Zhao SG, Sanford NN, Dess RT, Feng FY, D'Amico AV, Spratt DE, Yu JB, Nguyen PL, Rebbeck TR, et al. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Cancer. PMID 31251398 DOI: 10.1200/Jco.2019.37.7_Suppl.12 |
0.083 |
|
| 2024 |
Prezelski K, Hsu DG, Del Balzo L, Heller E, Ma J, Pike LRG, Ballangrud Å, Aristophanous M. Artificial-intelligence-driven measurements of brain metastases' response to SRS compare favorably with current manual standards of assessment. Neuro-Oncology Advances. 6: vdae015. PMID 38464949 DOI: 10.1093/noajnl/vdae015 |
0.072 |
|
| 2018 |
Sanford NN, Mahal BA, Royce TJ, Pike LRG, Hwang WL. Sex Disparity and Copy Number Alterations in Esophageal Squamous Cell Carcinoma. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 30120994 DOI: 10.1016/j.cgh.2018.08.026 |
0.069 |
|
| 2019 |
Sanford NN, Hwang WL, Pike LRG, Lam AC, Royce TJ, Mahal BA. Trimodality therapy for HPV-positive oropharyngeal cancer: A population-based study: Trimodality therapy for HPV+ OPC. Oral Oncology. 98: 28-34. PMID 31536843 DOI: 10.1016/j.oraloncology.2019.09.009 |
0.068 |
|
| 2018 |
Pike LRG, Hwang WL, Royce TJ, Sanford NN, Mahal BA. HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynx. Oral Oncology. 86: 69-74. PMID 30409322 DOI: 10.1016/j.oraloncology.2018.09.007 |
0.068 |
|
| 2022 |
Imber BS, O'Dwyer E, Lobaugh S, McBride SM, Hopkins M, Kollmeier M, Gorovets D, Brennan V, Pike LRG, Gewanter R, Mychalczak B, Zhang Z, Schöder H, Zelefsky MJ. Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation. Urology. PMID 36115426 DOI: 10.1016/j.urology.2022.08.035 |
0.068 |
|
| 2017 |
Bang A, Wilhite TJ, Pike LRG, Cagney DN, Aizer AA, Taylor A, Spektor A, Krishnan M, Ott PA, Balboni TA, Hodi FS, Schoenfeld JD. Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 98: 344-351. PMID 28463153 DOI: 10.1016/J.Ijrobp.2017.02.003 |
0.058 |
|
| 2022 |
Mathis NJ, Wijetunga NA, Imber BS, Pike LRG, Yang JT. Recent Advances and Applications of Radiation Therapy for Brain Metastases. Current Oncology Reports. PMID 35133614 DOI: 10.1007/s11912-022-01209-z |
0.058 |
|
| 2022 |
Moss NS, El Ahmadieh TY, Brown S, Chen J, Imber BS, Pike L, Reiner AS, Panageas KS, Brennan C, Tabar V, Beal K. Integrated Multidisciplinary Brain Metastasis Care Reduces Patient Visits and Shortens Time to Adjuvant Irradiation. Jco Oncology Practice. OP2200258. PMID 36037413 DOI: 10.1200/OP.22.00258 |
0.053 |
|
| 2023 |
Bander ED, El Ahmadieh TY, Chen J, Reiner AS, Brown S, Giantini-Larsen AM, Young RJ, Beal K, Imber BS, Pike LRG, Brennan CW, Tabar V, Panageas KS, Moss NS. Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases. Jama Network Open. 6: e2340654. PMID 37906192 DOI: 10.1001/jamanetworkopen.2023.40654 |
0.052 |
|
| 2020 |
Pike LRG, Royce TJ, Mahal AR, Kim DW, Hwang WL, Mahal BA, Sanford NN. Outcomes of HPV-Associated Squamous Cell Carcinoma of the Head and Neck: Impact of Race and Socioeconomic Status. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 177-184. PMID 32023531 DOI: 10.6004/jnccn.2019.7356 |
0.052 |
|
| 2023 |
Imber BS, Sehgal R, Saganty R, Reiner AS, Ilica AT, Miao E, Li BT, Riely GJ, Yu HA, Panageas KS, Young RJ, Pike LRG, Moss NS. Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC. Jto Clinical and Research Reports. 4: 100607. PMID 38124791 DOI: 10.1016/j.jtocrr.2023.100607 |
0.051 |
|
| 2024 |
Moore A, Zhang Z, Fei T, Zhang L, Accomando L, Schmitt AM, Higginson DS, Mueller BA, Zinovoy M, Gelblum DY, Yerramilli D, Xu AJ, Brennan VS, Guttmann DM, Grossman CE, ... ... Pike LRG, et al. 40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy. Neurosurgery. PMID 38456696 DOI: 10.1227/neu.0000000000002889 |
0.045 |
|
| 2023 |
Vasudevan HN, Delley C, Chen WC, Mirchia K, Pan S, Shukla P, Aabedi AA, Nguyen MP, Morshed RA, Young JS, Boreta L, Fogh SE, Nakamura JL, Theodosopoulos PV, Phillips J, ... ... Pike L, et al. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy. Jama Network Open. 6: e2329186. PMID 37589977 DOI: 10.1001/jamanetworkopen.2023.29186 |
0.043 |
|
| 2022 |
Saraf A, Pike LRG, Franck KH, Horick NK, Yeap BY, Fullerton BC, Wang IS, Abazeed ME, McKenna MJ, Mehan WA, Plotkin SR, Loeffler JS, Shih HA. Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial. Neurosurgery. PMID 35229827 DOI: 10.1227/NEU.0000000000001869 |
0.037 |
|
| 2023 |
Swinburne NC, Yadav V, Murthy KNK, Elnajjar P, Shih HH, Panyam PK, Santilli A, Gutman DC, Pike L, Moss NS, Stone J, Hatzoglou V, Shah A, Juluru K, Shah SP, et al. Fast, light, and scalable: harnessing data-mined line annotations for automated tumor segmentation on brain MRI. European Radiology. PMID 37042979 DOI: 10.1007/s00330-023-09583-3 |
0.025 |
|
| 2019 |
Pike LRG, D'Amico AV. Author Reply. Urology. 126: 151. PMID 30929689 DOI: 10.1016/j.urology.2018.11.058 |
0.016 |
|
| 2023 |
Lebow ES, Pike LRG, Seidman AD, Moss N, Beal K, Yu Y. Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases. Jama Oncology. PMID 37883079 DOI: 10.1001/jamaoncol.2023.4492 |
0.015 |
|
| 2019 |
Pike LRG, McKenna MJ, Shih HA. With Regard to the Brainstem, Size Matters Most. International Journal of Radiation Oncology, Biology, Physics. 103: 799-800. PMID 30784526 DOI: 10.1016/j.ijrobp.2018.11.023 |
0.01 |
|
| Hide low-probability matches. |